LKB1/AMPK pathway and drug response in cancer: a therapeutic perspective

F Ciccarese, E Zulato… - Oxidative medicine and …, 2019 - Wiley Online Library
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently
detected in non‐small‐cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 …

Advanced strategies for therapeutic targeting of wild-type and mutant p53 in cancer

S Zhang, L Carlsen, L Hernandez Borrero, AA Seyhan… - Biomolecules, 2022 - mdpi.com
TP53 is a tumor suppressor gene that encodes a sequence-specific DNA-binding
transcription factor activated by stressful stimuli; it upregulates target genes involved in …

Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma

E Flynt, K Bisht, V Sridharan, M Ortiz, F Towfic… - Cells, 2020 - mdpi.com
Multiple myeloma (MM) is the second most common hematological cancer and is
characterized by genetic features including translocations, chromosomal copy number …

Role of sex hormones in lung cancer

N Fuentes, M Silva Rodriguez… - … Biology and Medicine, 2021 - journals.sagepub.com
Lung cancer represents the world's leading cause of cancer deaths. Sex differences in the
incidence and mortality rates for various types of lung cancers have been identified, but the …

An overview on the relationship between residential radon and lung cancer: what we know and future research

A Ruano-Ravina, L Martin-Gisbert, K Kelsey… - Clinical and …, 2023 - Springer
We aim to provide an overview of the research available on indoor radon and lung cancer,
with a special focus on Spanish investigations. Early studies on underground miners …

TP53 status, patient sex, and the immune response as determinants of lung cancer patient survival

D Freudenstein, C Litchfield, F Caramia, G Wright… - Cancers, 2020 - mdpi.com
Lung cancer poses the greatest cancer-related death risk and males have poorer outcomes
than females, for unknown reasons. Patient sex is not a biological variable considered in …

Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status

H Zhang, G Zhang, M Xiao, S Cui, C Jin, J Yang… - Journal of Experimental …, 2024 - Springer
Abstract Background Activator protein-1 (AP-1) represents a transcription factor family that
has garnered growing attention for its extensive involvement in tumor biology. However, the …

Identification of a druggable protein–protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1

X Tong, D Xu, RK Mishra, RD Jones, L Sun… - Journal of Biological …, 2021 - ASBMB
The TP53 gene is the most frequently mutated gene in human cancers, and the majority of
TP53 mutations are missense mutations. As a result, these mutant p53 (mutp53) either …

Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review

R Thapa, AT Magar, J Shrestha, N Panth, S Idrees… - MedComm, 2024 - Wiley Online Library
Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence
among all types of cancer. The genetic interaction between human eukaryotes and microbial …

The Association between Polluted Neighborhoods and TP53-Mutated Non–Small Cell Lung Cancer

L Erhunmwunsee, SE Wing, J Shen, H Hu… - … Biomarkers & Prevention, 2021 - AACR
Background: Poor patients often reside in neighborhoods of lower socioeconomic status
(SES) with high levels of airborne pollutants. They also have higher mortality from non–small …